NASDAQ:ISRG News 7 December 2025 - 11 January 2026

Intuitive Surgical shares closed Friday at $586.24, up 0.2%, after Bernstein and Goldman Sachs raised their price targets to $740 and $714, respectively. The company will present at the J.P. Morgan Healthcare Conference on Jan. 14 and report Q4 earnings Jan. 22. Investors are focused on da Vinci 5 adoption and procedure growth. The stock’s 52-week range is $425 to $616.

Intuitive Surgical shares jumped 4.7% to $592.85 Tuesday, with trading volume topping 2.6 million shares. The stock now sits 3.8% below its 52-week high ahead of key company events on Jan. 14 and Jan. 22. Investors await management updates on demand and margins. U.S. economic data due Wednesday could influence rate-sensitive growth stocks.

Intuitive Surgical shares fell 1% to $560.61 in Friday’s afternoon trading, underperforming a mixed U.S. market on the first session of 2026. The move followed a management shift, with Chief Digital Officer Brian E. Miller taking a new role focused on digital and AI strategy. Medical-device stocks lagged, while broader healthcare edged higher. Investors are watching upcoming jobs and inflation data, plus the J.P. Morgan Healthcare Conference.

Intuitive Surgical shares fell 1.1% to $566.36 in the final 2025 trading session before U.S. markets closed for New Year’s Day. About 992,500 shares traded in a range between $565.77 and $573.28. The company’s next earnings call is set for Jan. 22. The S&P 500 ended the year down 0.74%, while the Nasdaq slipped 0.76%.

Intuitive Surgical shares traded near $577.15 ahead of the Dec. 26 session after the FDA cleared expanded uses for its da Vinci SP system on Dec. 10, including hernia and gallbladder procedures. The FDA recall database lists two open Class II recalls for da Vinci 5 components, posted Dec. 19, affecting 144 units due to an ergonomic connector issue that can cause delays or require system restarts.

Intuitive Surgical, Inc. (NASDAQ: ISRG) is ending the week in focus after a strong Friday close, fresh regulatory momentum for its single-port platform, and a new wave of Wall Street price-target updates heading into 2026. As of Dec. 20, 2025 (Saturday)—with U.S. markets closed—investors are digesting what’s next for the surgical robotics leader following a volatile December trading range and a busy stretch of headlines. Below is a detailed, publication-ready roundup of the current news, forecasts, and analyst commentary relevant as of 20.12.2025, plus what investors may be watching into early 2026. ISRG stock price today: where Intuitive Surgical shares

Intuitive Surgical, Inc. (NASDAQ: ISRG) is back in focus on Tuesday, December 16, 2025, after a strong rebound in the prior session and a fresh wave of market commentary ranging from technical-analysis signals to institutional-filings headlines and updated Wall Street expectations. As of late morning U.S. trading, ISRG traded around $548–$549, down roughly 2% on the day, valuing the surgical-robotics leader at about $194 billion in market capitalization. StockAnalysis+1 Below is a comprehensive, publication-ready roundup of the news, forecasts, and analyses circulating on 16.12.2025, plus the key catalysts investors are watching into early 2026. ISRG stock price today: a pullback

Intuitive Surgical, Inc. (NASDAQ: ISRG) ended Monday’s session (December 15, 2025) with a notable rebound—then slipped modestly in after-hours trading. For investors watching the robotic surgery leader into Tuesday’s open (December 16, 2025), the setup is a mix of stock-specific signals (including a new insider filing) and market-wide catalysts arriving before the bell. Below is what’s new today, what’s driving attention tonight, and the key checkpoints to monitor before the U.S. stock market opens tomorrow. ISRG after the bell: the closing move and the after-hours pulse ISRG rose 3.17% on Monday to close at $559.52, snapping a five-day losing streak

Intuitive Surgical, Inc. (NASDAQ: ISRG) is back in focus on December 15, 2025, as the robotic-surgery leader sees fresh attention from institutional-filing headlines, ETF flow commentary, and options-market activity—all landing on the same day the stock trades higher. While there wasn’t a single blockbuster earnings release or acquisition announced today, the day’s coverage paints a clear picture of why ISRG remains one of the most closely watched large-cap medtech names: it’s a dominant platform business with recurring revenue characteristics, strong procedure momentum (as last reported), and a valuation that keeps Wall Street debating how much growth is already priced in.

Updated: Friday, December 12, 2025 (U.S. market close)Company: Intuitive Surgical, Inc. (NASDAQ: ISRG) Intuitive Surgical stock finished the week on the back foot—even as the robotic-surgery leader delivered a meaningful regulatory win. Shares of ISRG closed at $542.32 on Friday, Dec. 12, capping a five-session slide from $566.89 on Monday, Dec. 8 (a decline of roughly 4.3% across the week). Nasdaq The pullback came amid a busy headline flow that investors often take seriously in high-multiple medtech names: FDA clearance expanding da Vinci SP’s U.S. indications, a Citigroup downgrade, a Wells Fargo price-target increase, and fresh insider-selling paperwork. TradingView+3GlobeNewswire+3TipRanks+3 Below

Intuitive Surgical, Inc. (NASDAQ: ISRG) finished the regular session on Friday, December 12, 2025, lower—but after-hours trading stayed quiet, suggesting no major late-breaking catalyst hit the tape after the closing bell. ISRG closed at $542.32, down $5.04 (-0.92%), after trading between $537.70 and $548.93 on the day, with about 2.08 million shares traded. Yahoo Finance+1 After the close, the stock was essentially flat, trading around $542.00 in late after-hours activity. Yahoo Finance One crucial calendar note before we get into the news roundup: December 13, 2025 is a Saturday, and U.S. stock markets are closed. So there’s no “Saturday open”

Intuitive Surgical stock today: where things stand Intuitive Surgical Inc. (NASDAQ: ISRG), the robotics and minimally invasive surgery leader behind the da Vinci and Ion platforms, continues to trade near the top of its 52‑week range as of December 7, 2025. Specialist services that track Intuitive Surgical’s price history also show a strong rebound over the last three months, with shares approaching their late‑January 2025 high around $616. StockInvest+1 Year to date, ISRG is up high single digits, according to recent analyst commentary, after a volatile first half of 2025 and a strong move following third‑quarter earnings. Forbes+1 The very